Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 1/2011

01.01.2011 | Original Paper

HIV Incidence and Prevalence Among Aboriginal Peoples in Canada

verfasst von: Katrina C. Duncan, Charlotte Reading, Alexandra M. Borwein, Melanie C. M. Murray, Alexis Palmer, Warren Michelow, Hasina Samji, Viviane D. Lima, Julio S. G. Montaner, Robert S. Hogg

Erschienen in: AIDS and Behavior | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

We examined incidence, prevalence, and correlates of HIV infection in Aboriginal peoples in Canada and found that among most risk groups both Aboriginal and non-Aboriginal participants showed similar levels of HIV prevalence. Aboriginal peoples who use illicit drugs were found to have higher HIV incidence and prevalence when compared to their non-Aboriginal drug-using peers. Aboriginal street youth and female sex workers were also found to have higher HIV prevalence. Among Aboriginal populations, correlates of HIV-positive sero-status include syringe sharing and frequently injecting drugs, as well as geographic and social factors such as living in Vancouver or having a history of non-consensual sex. This study is relevant to Canada and elsewhere, as Indigenous populations are disproportionately represented in the HIV epidemic worldwide.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Health Canada. HIV and AIDS in Canada. Surveillance report to June 30, 2002. Ottawa: Health Canada; 2002.
2.
Public Health Agency of Canada. Summary: estimates of HIV prevalence and incidence in Canada, 2008. Ottawa: Health Canada; 2008.
3.
Health Canada. First Nations and Inuit Health, 2006. Ottawa: Health Canada; 2006.
4.
Public Health Agency of Canada. HIV/AIDS among Aboriginal persons in Canada: a continuing concern. In: HIV/AIDS epi updates, November 2007. Ottawa: Health Canada; 2007.
5.
Public Health Agency of Canada. HIV/AIDS epi updates, November 2007. Ottawa: Public Health Agency of Canada; 2007.
6.
Health Canada. Understanding the HIV/AIDS epidemic among Aboriginal peoples in Canada: the community at a glance. Ottawa: Health Canada; 2004.
7.
De P, Singh AE, Wong T, Kaida A. Predictors of gonorrhea reinfection in a cohort of sexually transmitted disease patients in Alberta, Canada, 1991–2003. Sex Transm Dis. 2007;34:30–6.CrossRefPubMed
8.
Romanowski B, Preiksaitis J, Campbell P, Fenton J. Hepatitis C seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics. Sex Transm Dis. 2003;30:33–8.CrossRefPubMed
9.
Shields SA, Wong T, Mann J, et al. Prevalence and correlates of chlamydia infection in Canadian street youth. J Adolesc Health. 2004;34(5):384–90.PubMed
10.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896–900.CrossRefPubMed
11.
Public Health Agency of Canada. Inventory of HIV incidence and prevalence studies in Canada, August 2006. Ottawa: Public Health Agency of Canada; 2006.
12.
Pagano M, Gauvreau K. Principles of biostatistics. 2nd ed. Pacific Grove, CA: Duxbury; 2000.
13.
Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404–13.CrossRef
14.
Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–65.CrossRefPubMed
15.
Schecter M, Heath K, Strathdee SA, Palepu A, O’Shaughnessy MV. Determinants of HIV infection in a cohort of native Canadian injection drug users. In: XIIth international AIDS conference, June 28–July 3, 1998, Geneva, Switzerland (abstract).
16.
Miller CL, Tyndall M, Li K, Laliberte N, Spittal P, Schechter M. High rates of HIV positivity among young injection drug users. Can J Infect Dis. 2001;12(suppl B):340 (abstract).
17.
Miller CL, Spittal P, Laliberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002;30(3):335–41.PubMed
18.
Spittal PM, Craib KJP, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002;166(7):894–9.
19.
Craib KJP, Spittal PM, Wood E, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. Can Med Assoc J. 2003;168(1):19–24.
20.
Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–93.CrossRefPubMed
21.
O’Connell JM, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2005;40(1):83–8.CrossRefPubMed
22.
Spittal PM, Craib KJ, Schechter MT, Medd L, Barney L, Baylis C. HIV and HCV prevalence and risk factors among young Aboriginal drug users in Vancouver and Prince George, British Columbia. Can J Infect Dis Med Microbiol. 2005;16(suppl A):191 (abstract).
23.
Corneil TA, Kuyper LM, Shoveller J, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006;12(1):79–85.CrossRefPubMed
24.
Craib KJP, Moniruzzaman A, Schechter MT, Spittal PM. HIV and HCV prevalence and risk factors among Aboriginal youth that use injection drugs. Can J Infect Dis Med Microbiol. 2006;17(suppl A):356 (abstract).
25.
Miller CL, Strathdee SA, Spittal PM et al. Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting. Harm Reduct J. 2006;3:9.CrossRefPubMed
26.
Tyndall MW, Wood E, Zhang R, Lai C, Montaner JSG, Kerr T. HIV seroprevalence among participants at a supervised injection facility in Vancouver, Canada: implications for prevention, care and treatment. Harm Reduct J. 2006;3:36.CrossRefPubMed
27.
Maas B, Fairbairn N, Kerr T, Li K, Montaner JSG, Wood E. Neighborhood and HIV infection among IDU: place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007;13(2):432–9.CrossRefPubMed
28.
Spittal PM, Craib KJP, Tegee M, et al. The Cedar Project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities. Int J Circumpolar Health. 2007;66(3):226–40.PubMed
29.
Wood E, Lloyd-Smith E, Li K, et al. Frequent needle exchange use and HIV incidence in Vancouver, Canada. Am J Med. 2007;120(2):172–9.CrossRefPubMed
30.
Marshall BDL, Kerr T, Livingstone C, Li K, Montaner JSG, Wood E. High prevalence of HIV infection among homeless and street-involved Aboriginal youth in a Canadian setting. Harm Reduct J. 2008;5:35.
31.
Mehrabadi A, Craib KJP, Patterson K, et al. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Int J Drug Policy. 2008;19(2):159–68.CrossRefPubMed
32.
Mehrabadi A, Paterson K, Pearce M, et al. Gender differences in HIV and hepatitis C related vulnerabilities among Aboriginal young people who use street drugs in two Canadian cities. Women Health. 2008;48(3):235–60.CrossRefPubMed
33.
Pearce ME, Christian WM, Patterson K, et al. The Cedar Project: historical trauma, sexual abuse and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities. Soc Sci Med. 2008;66(11):2185–94.CrossRefPubMed
34.
Pearce ME, Christian WM, Patel SH, et al. The Cedar Project: experience of foster care and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities. Can J Infect Dis Med Microbiol. 2008;19(suppl A):262 (abstract).
35.
Schechter MT, Craib KJ, Clement K, et al. The Cedar Project: factors associated with HIV seroconversion among Aboriginal people who use injection and non-injection drugs in Vancouver and Prince George, British Columbia. Can J Infect Dis Med Microbiol. 2008;19(suppl A):266 (abstract).
36.
Wood E, Montaner JSG, Li K, et al. Burden of HIV infection among Aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health. 2008;98(3):515–9.CrossRefPubMed
37.
DeBeck K, Kerr T, Li K, et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Can Med Assoc J. 2009;181(9):585–9.CrossRef
38.
Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. Can Med Assoc J. 1994;151(6):781–7.
39.
Buxton JA, Rothon D, Durigon M, et al. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody on British Columbia. Can J Public Health. 2009;100(2):121–4.PubMed
40.
Martin JD, Mathias RG, Sarin C, Byrne SE. HIV and hepatitis B surveillance in First Nations alcohol and drug treatment centres in British Columbia, Canada, 1992–2000. Int J Circumpolar Health. 2002;61(2):104–9.PubMed
41.
Callaghan RC, Cull R, Vettese LC, Taylor L. A gendered analysis of Canadian Aboriginal individuals admitted to inpatient substance abuse detoxification: a three-year medical chart review. Am J Addict. 2006;15(5):380–6.CrossRefPubMed
42.
Heath KV, Cornelisse PGA, Strathdee SA, et al. HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men. Int J STD AIDS. 1999;10(9):582–7.CrossRefPubMed
43.
Ogilvie GS. Trends in care for HIV positive pregnant women in British Columbia, 1994–1999. Vancouver: University of British Columbia; 2001 (thesis).
44.
Money D, van Schalkwyk J, Maan E, et al. Perinatal outcomes in a cohort of ART treated HIV positive pregnant women in British Columbia. Can J Infect Dis Med Microbiol. 2007;18(suppl B):31 (abstract).
45.
Rekart ML, Chan S, Barnett J, Lawrence C, Manzon L. HIV and North American Aboriginal peoples. In: VIIth international AIDS conference, June 16–21, 1991, Florence, Italy (abstract).
46.
Hogg RS, Strathdee S, Kerr T, Wood E, Remis R. HIV prevalence among Aboriginal British Columbians. Harm Reduct J. 2005;2:26.CrossRefPubMed
47.
Shannon K, Bright V, Gibson K, Tyndall MW, the MAKA Project Partnership. Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada. Can J Public Health. 2007;98(6):465–9.PubMed
48.
Calzavara L, Ramuscak N, Burchell AN, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities. Can Med Assoc J. 2007;177(3):257–61.CrossRef
49.
Liu J, Remis RS, Myers T, Husbands W, Ogunnaike-Cooke S, Archibald CP. Ethno-racial variation in sexual behaviour and HIV infection among men who have sex with men (MSM): results from the Lambda study. Can J Infect Dis Med Microbiol. 2010;21(suppl B):22 (abstract).
50.
Linton AB, Singh MD, Turbow D, Legg TJ. Street youth in Toronto, Canada: an investigation of demographic predictors of HIV status among street youth who access preventive health and social services. J HIV AIDS Soc Serv. 2009;8(4):375–96.CrossRef
51.
Romanowski B, Campbell PJ, Preiksaitis JK, Fonseca K. Human immunodeficiency virus seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics in Alberta. Sex Transm Dis. 1997;24(8):487–94.CrossRefPubMed
52.
Houston S, Mashinter L, Rowe B, Joffe M, Preiksaitis JK, Jhangri G. An anonymous unlinked seroprevalence study of HIV in urban Canadian Emergency Departments. Can J Infect Dis Med Microbiol. 2010;21(suppl B):62 (abstract).
53.
Wylie JL, Shah L, Jolly AM. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada. BMC Public Health. 2006;6:229.
54.
Siushansian J, Archibald CP, Lior LY, et al. Northern exposures: HIV and HCV spread among injection drug users in a small Canadian community. In: XIIIth international AIDS conference, July 9–14, 2000, Durban, South Africa (abstract).
55.
Weber AE, Chan K, George C, et al. Risk factors associated with HIV infection among young gay and bisexual men in Canada. J Acquir Immune Defic Syndr. 2001;28(1):81–8.PubMed
56.
Hankins C, Hum L, Tran T, et al. Low HIV prevalence among childbearing women of Aboriginal origin. AIDS. 1997;11(7):945–7.PubMed
57.
Mai N, Patrick D, Houston S, et al. HIV among aboriginal people in Canada: injection drug use is a main concern. In: XIIth international AIDS conference, June 28–July 3, 1998, Geneva, Switzerland (abstract).
58.
Forbes J, Alimenti A, Ayers D, et al. Perinatal HIV therapy and vertical transmission in Aboriginal mother-infant pairs living in Canada: data from the Canadian Perinatal HIV Surveillance Program (CPHSP) 1997–2008. Can J Infect Dis Med Microbiol. 2010;21(suppl B):28 (abstract).
59.
Mill JE, Jackson RC, Worthington CA, et al. HIV testing and care in Canadian Aboriginal youth: a community based mixed methods study. BMC Infect Dis. 2008;8:132–45.CrossRefPubMed
60.
McInnes CW, Druyts E, Harvard SS, et al. HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J. 2009;6:5.CrossRefPubMed
61.
Druyts EF, Rachlis BS, Lima VD, et al. Mortality is influenced by locality in a major HIV/AIDS epidemic. HIV Med. 2009;10(5):274–81.CrossRefPubMed
62.
Joy R, Druyts EF, Brandson EK, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5.CrossRefPubMed
63.
Larkin J, Flicker S, Koleszar-Green R, Mintz S. HIV risk, systemic inequities, and Aboriginal youth: widening the circle for HIV prevention programming. Can J Public Health. 2007;98(3):179–82.PubMed
64.
Sinha MM. Sex, structural violence, and AIDS: case studies of Indian prostitutes. Women’s Stud Q. 1999;27(1/2):65–72.
65.
Waldram JB, Herring DA, Young TK. Aboriginal health in Canada: historical, cultural, and epidemiological perspectives. Toronto: University of Toronto Press; 1995.
66.
Canada Mortgage and Housing Corporation. 2001 census housing series issue 6: revised Aboriginal households. Canada: CMHC; 2001.
67.
Fenton L. Preventing AIDS through poverty reduction: the only sustainable solution? Lancet. 2004;364(9440):1186–7.CrossRefPubMed
68.
Shelton JD, Cassel MM, Adetunji J. Is poverty or wealth the root of HIV? Lancet. 2005;366(9491):1057–8.CrossRefPubMed
69.
Stillwaggon E. HIV/AIDS in Africa: fertile terrain. J Dev Stud. 2002;38(6):1–22.
70.
Larkin JA. Women, poverty and HIV infection. Can Womens Stud. 2000;20(3):137–41.
71.
Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008;70(5):606–11.CrossRefPubMed
72.
Oetzel J, Duran B. Intimate partner violence in American Indian and/or Alaska native communities: a social ecological framework of determinants and interventions. Am Indian Alsk Native Ment Health Res. 2004;11(3):49–68.PubMed
Metadaten
Titel
HIV Incidence and Prevalence Among Aboriginal Peoples in Canada
verfasst von
Katrina C. Duncan
Charlotte Reading
Alexandra M. Borwein
Melanie C. M. Murray
Alexis Palmer
Warren Michelow
Hasina Samji
Viviane D. Lima
Julio S. G. Montaner
Robert S. Hogg
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9792-y

Weitere Artikel der Ausgabe 1/2011

AIDS and Behavior 1/2011 Zur Ausgabe

OriginalPaper

Behavioral Surveillance of Heterosexual Exchange-Sex Partnerships in San Francisco: Context, Predictors and Implications

Original Paper

Intimate Partner Violence Perpetration and Condom Use-Related Factors: Associations with Heterosexual Men’s Consistent Condom Use

Original Paper

Alcohol Consumption is Associated with Poor Health in HIV Clinic Patient Population: A Behavioral Surveillance Study

Original Paper

Sexual Serosorting among Women with or at Risk of HIV Infection

Original Paper

HIV Risk Behaviors: Risky Sexual Activities and Needle Use Among Adolescents in Substance Abuse Treatment

Original Paper

Depression Among HIV-Positive Individuals in Botswana: A Behavioral Surveillance

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise